Thank you for your interest in the Department of Neurology at the Medical College of Georgia at Augusta University.
Our department aims for the highest quality of clinical care, the best training experience for our medical students, residents, and fellows, and the performance of cutting-edge research. We have a strong foundation in general neurology and neurological subspecialties including stroke/telestroke, general neurology/headache, movement disorders, neurocognitive disorders, epilepsy, neuromuscular disorders, multiple sclerosis, clinical neurophysiology, neuropsychology, neuro-critical care, interventional neurology and pediatric neurology. We are the hub for a pioneering 29 spoke telestroke network and a JC certified Comprehensive Stroke Center (first in Georgia), a National Parkinson’s Foundation Center of Excellence, a NAEC Level 4 Epilepsy Center, and the only ALS Association Certified Center in Georgia. The department’s teaching mission includes medical students, residents, and fellows undergoing advanced training. Research activities in the department include both basic science and clinical and translational investigations. Additionally, our multidisciplinary Neuroscience Center of Excellence facilitates active collaborations with subspecialists from other departments including general neurosurgery, neuroradiology, neuro-otology, neuro-ophthalmology, functional neurosurgery (deep brain stimulation and epilepsy surgery), neuro-gastroenterology and basic scientists. Our facility houses a wide variety of other specialties including a level I trauma center, and seven ICUs (neurology, shock trauma, surgery, pediatric, neonatal, cardiology, and medical).
Department of Neurology News and Events
Department of Neurology Research
We study the distributions and determinants of diseases and health conditions in populations.
Neurology Alumni
Link to AU Health
When the brain isn’t getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.
A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle.
Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.
Traditional stroke treatments like clot-dissolving tPA and surgical removal of big clots in the brain are good choices as well when the stroke results from SARS-CoV-2 infection, investigators report.
 |
 |
 |
Department of Neurology
Health Sciences Campus
706-721-4581
706-721-1459
